Virogin Biotech was founded in Canada in 2015, with a vision to be a global, best-in-class oncolytic virus company that creates impactful drugs for patients with the highest medical need.
We have over 170 employees, with R&D facilities in Canada and China.
At Virogin, we are at the forefront of developing novel oncolytic virotherapies. For every decision we make in the workplace, we think of the patients first.
Oncolytic virotherapy is among the most promising agents to induce immunogenicity and overcome immune-suppressive barriers in so-called “cold tumors” or relapsed/refractory patient populations.
Strategic Collaboration with MD Anderson Cancer Center
Virogin USA established
VG161 US IND approval; VG201 US IND approval
Initiated construction of R&D and Manufacturing Center, Shanghai
CNBG-Virogin Joint Venture established
Virogin Biotech Australia established
Shanghai Virogin Biotech established
Seed Financing; Shenzhen Virogin Biotech established
Virogin Biotech Hong Kong established; Virogin Biotech Canada established
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.